# A Trial of Pre-Operative Chemoradiotherapy Using Capecitabine, Radiation & Cetuximab, in Rectal Cancer

> **NCT01310985** · — · COMPLETED · sponsor: **King Faisal Specialist Hospital & Research Center** · enrollment: 15 (actual)

## Conditions studied

- Colon Rectal Cancer Duke Stage Stageval

## Interventions

- **DRUG:** Capecitabine (Xelodaâ), XRT & Cetuximab (Erbitux®)

## Key facts

- **NCT ID:** NCT01310985
- **Lead sponsor:** King Faisal Specialist Hospital & Research Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2019-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01310985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01310985, "A Trial of Pre-Operative Chemoradiotherapy Using Capecitabine, Radiation & Cetuximab, in Rectal Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01310985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*